CS216828B2 - Method of making the phenylalkylamine - Google Patents

Method of making the phenylalkylamine Download PDF

Info

Publication number
CS216828B2
CS216828B2 CS756837A CS683777A CS216828B2 CS 216828 B2 CS216828 B2 CS 216828B2 CS 756837 A CS756837 A CS 756837A CS 683777 A CS683777 A CS 683777A CS 216828 B2 CS216828 B2 CS 216828B2
Authority
CS
Czechoslovakia
Prior art keywords
group
formula
compound
compounds
hydrogen atom
Prior art date
Application number
CS756837A
Other languages
Czech (cs)
English (en)
Inventor
Kurt Schromm
Anton Mentrup
Brnst Renth
Ludwig Pichler
Werner Traunecker
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CS216828B2 publication Critical patent/CS216828B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS756837A 1974-04-27 1975-04-25 Method of making the phenylalkylamine CS216828B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2420618A DE2420618C2 (de) 1974-04-27 1974-04-27 Aminoalkylanilide, Verfahren zu ihrer Herstellung sowie pharmazeutische Zubereitungen, die diese Aminoalkylanilide enthalten

Publications (1)

Publication Number Publication Date
CS216828B2 true CS216828B2 (en) 1982-11-26

Family

ID=5914207

Family Applications (2)

Application Number Title Priority Date Filing Date
CS756837A CS216828B2 (en) 1974-04-27 1975-04-25 Method of making the phenylalkylamine
CS752917A CS216827B2 (en) 1974-04-27 1975-04-25 Method of making the phenylalkylamine

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS752917A CS216827B2 (en) 1974-04-27 1975-04-25 Method of making the phenylalkylamine

Country Status (27)

Country Link
US (1) US4015011A (fi)
JP (1) JPS5828269B2 (fi)
AT (1) AT350529B (fi)
BE (1) BE828430A (fi)
BG (2) BG26372A4 (fi)
CA (1) CA1061357A (fi)
CH (3) CH614697A5 (fi)
CS (2) CS216828B2 (fi)
DD (1) DD122374A5 (fi)
DE (1) DE2420618C2 (fi)
DK (1) DK180675A (fi)
ES (7) ES437032A1 (fi)
FI (1) FI63931C (fi)
FR (1) FR2268520B1 (fi)
GB (1) GB1501436A (fi)
HU (1) HU172615B (fi)
IE (1) IE42119B1 (fi)
IL (1) IL47170A (fi)
NL (1) NL7504917A (fi)
NO (1) NO141207C (fi)
PH (2) PH11982A (fi)
PL (2) PL96224B1 (fi)
RO (2) RO81766A (fi)
SE (2) SE411205B (fi)
SU (2) SU555843A3 (fi)
YU (1) YU105275A (fi)
ZA (1) ZA752685B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163060A (en) * 1974-04-08 1979-07-31 U.S. Philips Corporation Aralkylamino carboxylic acids and derivatives having spasmolytic activity
US4146645A (en) * 1974-04-27 1979-03-27 Boehringer Ingelheim Gmbh Hypertensive phenylalkylamines and salts thereof
US4145363A (en) * 1975-02-05 1979-03-20 Yamanouchi Pharmaceutical Co., Ltd. 4-Carbamoylamino-α-aminomethylbenzyl alcohol derivatives
US4088785A (en) * 1976-03-25 1978-05-09 William H. Rorer, Inc. Amidinoureas for the treatment of cardinascular disorders
US4754047A (en) * 1979-08-16 1988-06-28 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and/or improving the efficiency of feed utilization thereby
US4477470A (en) * 1983-10-20 1984-10-16 Smithkline Beckman Corporation Method for producing diuresis using m-amino-α-methylphenethylamine
JPS6155683U (fi) * 1984-09-17 1986-04-14
JPS61130876U (fi) * 1984-09-18 1986-08-15
AU4945185A (en) * 1984-11-08 1986-05-15 Syntex (U.S.A.) Inc. Dialkyl aminoethylaniline derivatives
US4752621A (en) * 1985-04-11 1988-06-21 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
US4798687A (en) * 1987-02-06 1989-01-17 Pennwalt Corporation 2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives
JPH01116183U (fi) * 1988-01-29 1989-08-04
JPH01116184U (fi) * 1988-01-29 1989-08-04
US5741818A (en) * 1995-06-07 1998-04-21 University Of Saskatchewan Semicarbazones having CNS activity and pharmaceutical preparations containing same
BR9809288A (pt) 1997-04-22 2001-08-07 Cocensys Inc Semicarbazonas e tiosemicarbazonas substituìdas carbocìclicas e heterocìclicas e utilização das mesmas
EP1561744B1 (en) * 1997-08-05 2007-04-18 Pola Chemical Industries Inc. Amine derivatives, process for producing the same and their use as antimycotic agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123536C (fi) * 1963-07-09

Also Published As

Publication number Publication date
FR2268520A1 (fi) 1975-11-21
GB1501436A (en) 1978-02-15
IE42119L (en) 1975-10-27
IL47170A0 (en) 1975-06-25
US4015011A (en) 1977-03-29
IE42119B1 (en) 1980-06-04
ES452515A1 (es) 1977-11-01
ES452511A1 (es) 1977-11-01
BG27738A3 (en) 1979-12-12
ES452510A1 (es) 1977-11-01
FI63931C (fi) 1983-09-12
ATA247875A (de) 1978-11-15
IL47170A (en) 1980-07-31
ES452513A1 (es) 1977-11-01
SE7810002L (sv) 1978-09-22
CH616146A5 (fi) 1980-03-14
NO141207C (no) 1980-01-30
PH14732A (en) 1981-11-19
YU105275A (en) 1982-02-28
SU606549A3 (ru) 1978-05-05
NO141207B (no) 1979-10-22
DK180675A (da) 1975-10-28
ZA752685B (en) 1976-12-29
HU172615B (hu) 1978-11-28
RO70894A (ro) 1982-02-26
RO81766A (ro) 1983-06-01
AT350529B (de) 1979-06-11
ES452514A1 (es) 1977-11-01
JPS5828269B2 (ja) 1983-06-15
ES452512A1 (es) 1977-11-01
DE2420618A1 (de) 1975-11-13
SU555843A3 (ru) 1977-04-25
SE7504858L (sv) 1975-10-28
JPS50149630A (fi) 1975-11-29
CA1061357A (en) 1979-08-28
FI63931B (fi) 1983-05-31
CH614697A5 (fi) 1979-12-14
FR2268520B1 (fi) 1982-02-12
NO751491L (fi) 1975-10-28
PL96224B1 (pl) 1977-12-31
PH11982A (en) 1978-10-04
CH616401A5 (fi) 1980-03-31
RO81766B (ro) 1983-05-30
DE2420618C2 (de) 1982-09-16
SE411205B (sv) 1979-12-10
CS216827B2 (en) 1982-11-26
AU8051075A (en) 1976-10-28
FI751199A (fi) 1975-10-28
ES437032A1 (es) 1977-04-16
DD122374A5 (fi) 1976-10-05
NL7504917A (nl) 1975-10-29
BG26372A4 (bg) 1979-03-15
BE828430A (fr) 1975-10-27
PL96308B1 (pl) 1977-12-31

Similar Documents

Publication Publication Date Title
US3253037A (en) N-2-alkynyl-amino-benzocylo-alkanes
CS216828B2 (en) Method of making the phenylalkylamine
US3542872A (en) 1-amino substituted phenoxy-2-hydroxy-3-isopropylamino-propanes
US4122193A (en) Drugs or medicines for influencing the central nervous system
US3644469A (en) 1-(cyanophenoxy)-2-hydroxy-3-sec.-alkylamino-propanes
US3872147A (en) 1-phenoxy-2-hydroxy-3-alkylamino-propanes
GB2133788A (en) Phenethylamine derivatives
US4029731A (en) Aminophenyltetralin compounds
US3755413A (en) 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
EP0047536A2 (en) Substituted propylamines
US4045488A (en) Aminophenyltetralin compounds
US3000903A (en) Phenylalkylhydrazines and use as psychotherapeutics
US3742023A (en) Novel 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes
US3711545A (en) Alpha-aminoalkyl-4-hydroxy-3-sulfamoylaminobenzyl alcohols
US3917704A (en) Alpha-aminoalkyl-4-hydroxy-3-alkylsulfonylmethylbenzyl alcohols
US3097136A (en) Process for producing a depressant-like effect on the central nervous system
US3829441A (en) Guanidinoalkylbenzodioxan derivatives
US3360529A (en) Guanidinoalkylbenzodioxan derivatives
US3976694A (en) α-Aminoalkyl-4-hydroxy-3-alkylsulfonylmethylphenyl ketones
US3515741A (en) 1-cyanophenoxy-2-amino-alkanes
EP0026989B1 (en) Nitrosourea derivatives, process for preparing them, and pharmaceutical compositions containing them
US3943173A (en) 3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols
GB2120251A (en) Dihydropyridines
US3127405A (en) I-phenylalkyl
US4004028A (en) Phenoxypropanolamines